Skip to main content
Clinical Trials/NCT00957255
NCT00957255WithdrawnNot Applicable

Rotator Cuff Repair (RCR) With and Without OrthoADAPT Augmentation

Baxter Healthcare Corporation2 sites in 1 countryStarted: March 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Withdrawn
Locations
2
Primary Endpoint
Pain

Study Overview

Brief Summary

Prospective, randomized, multi-center, controlled study for patients undergoing open rotator cuff repair. Patients are stratified based on tear size to one of three groups. Each group is then randomized 1:1 to either repair with OrthoADAPT or repair without OrthoADAPT.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Ages 18-70
  • MRI confirmed full thickness or high grade partial thickness rotator cuff tear equal or more than 1 cm and involving the supraspinatus and/or infraspinatus tendons
  • Tear is repairable by surgery using protocol prescribed fixation procedure
  • Patient is able to sign and IRB approved study informed consent
  • Patient is willing and able to return for follow-up appointments and study related procedures
  • Patient is willing to comply with prescribed physical therapy regimen

Exclusion Criteria

  • Emergency, poly trauma patients
  • Prior same shoulder surgery including rotator cuff repair except prior subacromial decompression or distal clavicle resection
  • Shoulder pathology requiring concomitant procedures during the rotator cuff repair including Labral repair, anterior or posterior stabilization, and/or capsular plication or shift
  • Cervical spine disease
  • History of adhesive capsulitis in either shoulder
  • Patient whose injury does or may involve litigation
  • Diabetics
  • Rotator cuff tear cannot be repaired by primary surgical means including superiorly migrated humeral head, retracted rotator cuff that cannot be mobilized to humeral head, end stage tears, rotator cuff tissue cannot retain sutures, any comorbidities that would directly or indirectly affect the reparability of the cuff
  • Patients with grade 3 or 4 glenohumeral arthritis
  • Patients with systemic collage disease
  • Patients with a known hypersensitivity to equine derived materials
  • Active or latent infection
  • Chronic use of immunosuppressive agents
  • Any oral or IM NSAID usage within 5 days before surgery
  • Cancer patients
  • Decisional impaired patients
  • Pregnant women

Outcomes

Primary Outcomes

Pain

Time Frame: Pre-op, 2, 3, 4, and 6 weeks, 3, 4, 6, 12 and 24 months

Passive and active range of motion

Time Frame: Pre-op, 6 weeks, 3, 4, 6, 12, and 24 months

American Shoulder and Elbow Surgeons assessment score

Time Frame: Pre-op, 6 weeks, 3, 4, 6, 12, and 24 months

Constant shoulder score

Time Frame: Pre-op, 6 weeks, 3, 4, 6, 12, and 24 months

Secondary Outcomes

  • MRI(12 months)
  • Rotator cuff re-rupture and adhesions(6 weeks, 3, 4, 6, 12 and 24 months)
  • Incidence of device or procedure related adverse events(6 weeks, 3, 4, 6, 12, and 24 months)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Rotator Cuff Repair (RCR) With and Without... | Clinical Trial